Celldex Therapeutics to Present at the Wedbush PacGrow 2012 Life Sciences: Management Access Conference
NEEDHAM, Mass.--(BUSINESS WIRE)--Aug. 8, 2012--
Celldex
Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S.
Marucci, President and Chief Executive Officer of
Celldex Therapeutics,
Inc., will present at the Wedbush PacGrow 2012 Life Sciences:
Management
Access Conference in
New York City on
Wednesday, August 15, 2012 at
9:45
a.m. ET. A live webcast of the Company’s presentation will be available
online on the “Presentations” page of the “Investors” section of the
Celldex website at
http://www.celldextherapeutics.com
and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination
immunotherapy company. Celldex has a pipeline of drug candidates in
development for the treatment of cancer and other difficult-to-treat
diseases based on its antibody focused Precision Targeted Immunotherapy
(PTI) Platform. The PTI Platform is a complementary portfolio of
monoclonal antibodies, antibody-targeted vaccines and immunomodulators
used in optimal combinations to create novel disease-specific drug
candidates. For more information, please visit http://www.celldextherapeutics.com.
Source: Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.
Anthony S. Marucci, 781-433-0771
President
and CEO
or
Avery W. Catlin, 781-433-0771
Chief Financial
Officer
IR@celldextherapeutics.com
or
For
Media:
BMC Communications
Brad Miles, 646-513-3125
bmiles@bmccommunications.com
